News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

PPD Signs Agreement to Use Tessella and Berry Consultants' Adaptive Trial Design Software



11/14/2012 9:49:12 AM

WILMINGTON, N.C., & NEWTON, Mass.--(BUSINESS WIRE)--Pharmaceutical Product Development, LLC (PPD) has signed a license agreement to use Tessella and Berry Consultants’ FACTSTM software to create a more flexible, intuitive approach for designing both adaptive and fixed trials. The software expands PPD’s adaptive design capabilities by giving biopharmaceutical companies greater ability to use extensive simulations to investigate various study design options. These simulations are particularly useful for adaptive designs, where different options are available for making adjustments to an ongoing trial based on a set of pre-specified conditions, but they also can be used with fixed designs.

Read at BioSpace.com


comments powered by Disqus
 
 

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES